Form 4 Tracker
SOPHiA GENETICS SA
SOPH

134 insider filings · Latest: Oct 13, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 21, 2026Jul 21 8:24 PMJURGI CAMBLONG
Proposed Sale
37,000$6.33$234.2K—

View →

Jul 20, 2026Jul 20 8:15 PMJURGI CAMBLONG
Proposed Sale
24,381$5.87$143.1K—

View →

Jul 13, 2026Jul 14 8:02 PMPhilippe MenuChief Medical Officer
Sale
5,000$5.70$28.5K228,387(D)

View →

Jul 13, 2026Jul 14 8:02 PMZhenyu XuChief Scientific Officer
Sale
4,000$5.70$22.8K610,887(D)

View →

Jul 10, 2026Jul 14 8:02 PMJurgi CamblongDirector, Executive Chairman
Sale
8,500$5.62$47.8K3,532,622(D)

View →

Jul 7, 2026Jul 8 8:01 PMJurgi CamblongDirector, Executive Chairman
Sale
17,685$5.28$93.3K3,541,122(D)

View →

Jul 7, 2026Jul 7 8:40 PMJURGI CAMBLONG
Proposed Sale
24,290$5.34$129.7K—

View →

Jul 6, 2026Jul 7 8:04 PMGeorge CardozaChief Financial Officer
Sale
1,592$5.29$8.4K309,092(D)

View →

Jul 6, 2026Jul 7 8:03 PMManuela ValenteChief People Officer
Sale
4,241$5.05$21.4K210,450(D)

View →

Jul 6, 2026Jul 7 8:03 PMAbhimanyu VermaChief Technology Officer
Sale
5,285$5.10$27.0K192,171(D)

View →

Jul 6, 2026Jul 7 8:03 PMZhenyu XuChief Scientific Officer
Sale
7,393$5.17$38.2K614,887(D)

View →

Jul 6, 2026Jul 7 8:03 PMRoss MukenDirector, Chief Executive Officer
Sale
9,838$5.22$51.4K670,651(D)

View →

Jul 6, 2026Jul 7 8:03 PMKevin PuylaertChief Sales Officer
Sale
216$5.03$1.1K147,948(D)

View →

Jul 6, 2026Jul 7 8:03 PMPhilippe MenuChief Medical Officer
Sale
7,393$5.16$38.2K233,387(D)

View →

Jul 6, 2026Jul 7 8:03 PMJurgi CamblongDirector, Executive Chairman
Sale
22,486$5.26$118.2K3,558,807(D)

View →

Jul 6, 2026Jul 6 8:42 PMPHILIPPE MENU
Proposed Sale
32,393$5.35$173.3K—

View →

Jul 6, 2026Jul 6 8:42 PMZHENYU XU
Proposed Sale
19,393$5.35$103.8K—

View →

Jul 6, 2026Jul 6 8:39 PMGEORGE CARDOZA
Proposed Sale
1,592$5.35$8.5K—

View →

Jul 6, 2026Jul 6 8:31 PMROSS J MUKEN
Proposed Sale
9,838$5.35$52.6K—

View →

Jul 6, 2026Jul 6 8:27 PMMANUELA VALENTE
Proposed Sale
4,241$5.35$22.7K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 2, 2026Apr 8 12:46 PMAbhimanyu VermaChief Technology Officer
Grant/Award
119,760$5.04119,760(D)

View →

Apr 2, 2026Apr 3 10:59 AMAbhimanyu VermaChief Technology Officer
Grant/Award
119,760$5.04119,760(D)

View →

Apr 2, 2026Apr 3 10:59 AMRoss MukenPresident
Grant/Award
628,743$5.04628,743(D)

View →

Apr 2, 2026Apr 3 10:59 AMPhilippe MenuChief Medical Officer
Grant/Award
164,671$5.04164,671(D)

View →

Apr 2, 2026Apr 3 10:59 AMZhenyu XuChief Scientific Officer
Grant/Award
164,671$5.04164,671(D)

View →

Apr 2, 2026Apr 3 10:59 AMJurgi CamblongDirector, Chief Executive Officer
Grant/Award
628,743$5.04628,743(D)

View →

Apr 2, 2026Apr 3 10:59 AMKevin PuylaertChief Sales Officer
Grant/Award
82,335$5.0482,335(D)

View →

Apr 2, 2026Apr 3 10:59 AMGeorge CardozaChief Financial Officer
Grant/Award
164,671$5.04164,671(D)

View →

Apr 2, 2026Apr 3 10:58 AMManuela ValenteChief People Officer
Grant/Award
104,790$5.04104,790(D)

View →

Apr 2, 2026Apr 3 10:58 AMWell Daan VanChief Legal Officer
Grant/Award
142,216$5.04142,216(D)

View →

← Previous

Page 2 of 2